PATENT CLAIM ANALYSIS

Application Number: 15752765
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-12
Patent Classification: ["424", "093100"]

Abstract:
The present invention relates to in vitro cultured senescent cells, such as epithelial cells, keratinocytes and/or fibroblasts as well as their use in the treatment of tissue regeneration, particularly for the treatment of wounds such as burns or ulcers or the treatment of inflammatory conditions. Optionally, products may be used in combination with further drugs including antimicrobial or antidiabetic agents.

Claim (Index 23):
The method according to  claim 1 , wherein senescent cells express and/or secrete at least one or more of IL-8, GRO\u03b1, VEGF, endothelin, MMP7, MMP9, MMP10, MMP12, MMP13, TIMP1, TIMP2 and TGF-\u03b21.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 1.40426
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15080991', '15455684', '15827539', '15455575', '15647688']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7202909041277689
- 35 USC 102 Novelty (BERT): 0.5117938244277881
- Combined Prediction Score: 0.6994411961577709
- Mean Citation Score: 213.13589
- Max Citation Score: 218.5444
- Similarity Product: 122.98559661478994

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test